Women executives who reach the top in finance are reshaping the profession while creating newfound value for their companies, ...
Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...
Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe in patients with ...
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
The students, thereafter, knocked at the doors of Gujarat HC which ordered the BCG to issue the certificate to the students ...
The Bangladesh Coast Guard continues its regular operations to ensure security in coastal and riverine areas and curb smuggling and drug trafficking. Acting on confidential intelligence, it was ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...
BCG predicts rising temperatures will increase default risk in 30% of agri and housing loans by 2030, highlighting climate ...